- Albany Med Health System eyes affiliation with Ellis Medicine
- 1.4 million patients, 7 health systems caught in AI company data breach
- Banner Health clinicians file to unionize
- New Hampshire system names new chief strategy officer
- 8 recent studies on AI in diagnosis and clinical reasoning
- HHS launches Operation TrailBlazer to speed clinical trials: 5 notes
- Iowa 1st to fully allocate year 1 rural health funds
- ‘I would love to tell Mark Cuban to get involved’: What physician consolidation is costing patients
- Illinois passes bill regulating dental reimbursement practices
- The shifting dental care landscape
- Duke Health names ophthalmology chair
- Health insurer CEOs could face criminal liability for denials that lead to injury, death under Pennsylvania bill
- Texas hospital taps new COO
- Harvard to end faculty dental practice, transfer clinic to private owner due to financial constraints
- A physician’s plan to bring back practice autonomy to South Carolina
- Cardiologists push back on expansion of WISeR model
- Are ASCs ready for CMS’ new oversight rules?
- MCNA Dental agrees to multimillion-dollar settlement over 2023 ransomware attack
- Former Iowa dental office employee accused of using patient financial information for personal purchases
- Optum Behavioral Health names chief medical officer
- Stark law’s $632 million reckoning: The 5 biggest cases in 5 years
- ASCs’ robot evidence problem
- United Concordia expands dental coverage for patients with chronic conditions
- Who’s winning, losing the physician practice acquisition race?
- OIG flags Pennsylvania behavioral insurer for faulty prior auth denials
- Independence Health to open 28-bed behavioral health unit
- ICON Dental Partners appoints VP of dental partnerships
- These 'socially responsible' hospitals deliver on quality, value and equity
- Heartland Dental adds Missouri practice
- 4 dentists making headlines
- Growing ketamine use raises safety concerns
- AI’s growing role in mental healthcare: 5 notes
- Does ASC consolidation have a ceiling?
- Washington lawmakers eye corporate medicine ban after Oregon’s PeaceHealth test
- Pennsylvania cardiology group opens new $8.2M ASC
- Patient portal messages doubled since 2020, study finds, underscoring challenges to physician workloads
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Ensemble Health Partners secures strategic growth investment from Thoreau
- Hospital margins inched higher in April, but still remain below 2025
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CARsgen makes history as China approves world's first CAR-T therapy for solid tumors
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- US to investigate Germany's proposed drug spending reforms
- Alnylam scolded over promotional activity after Pfizer complaint
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Prosper AI lands $30M backed by Andreessen Horowitz to build AI workforce for healthcare operations
- Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- A 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition
- 1st free dental clinic opens in New Jersey
- 8 new behavioral health projects to know
- Oregon prosecutors urge state to fix mental health system
- The case for layering behavioral healthcare models
- Rural, independent Kansas hospitals launch clinically integrated network
- 12 behavioral health services, facility closures | 2026
- Higher, short-acting opioid doses linked to 8% lower discharge risk: 4 notes
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Why a deviation investigation still takes two weeks in the age of AI
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- Preparing for LEAD: Why post-acute visibility is the key to long-term value-based success
- One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- OhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuit
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- OIG report raises red flags about maternal health 'ghost networks' in Medicaid managed care
- Why It’s Time to Sunset AI Point Solutions and Consolidate Platforms
- Lantern, Marathon Health team up to launch integrated care management model
- The New Frontier of Care Management: Bridging the Empathy Gap with Intelligence
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- Whoop, HealthEx partner to connect members’ medical records and biometric data
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- After FDA sign-off, Colorado's drug import plan faces tough road ahead
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Why one life insurer is going big on health incentives
- Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI tool for healthcare marketers
- Before you build or buy care navigation AI, answer this
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Health services deal value holds steady in 2026 with higher bar for investment: PwC
- Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- 'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- FDA, UK drug regulator deepen transatlantic ties with new liaison program
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand
- Organic Baby Formula Recalled Following Botulism Cases
- FDA Approves First Over-the-Counter Glucose Monitor for Children, The Stelo Glucose Biosensor System
- You've Won The Game
- Many Patients Stop And Restart GLP-1 Meds, Study Finds
- Half Of U.S. Parents Track Their Adult Children’s Location
- Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting
- Trust In CDC Plummets Under Trump Administration, New Poll Shows
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
- Base Case: Remarks at the IC3 Blockchain Camp
- Eli Lilly cuts 340B discounts for hospitals resisting its claims data submission policy
- Eli Lilly cuts 340B discounts for hospitals resisting its claims data submission policy
- Commission Statement on the Passing of Former General Counsel David Becker
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Keynote Remarks at the 2026 Reagan National Economic Forum
Michigan healthcare freedom community forum
Astounding.
We have an insulin shortage, so our our legislature proposes Bills 1 and 2 - replete with perhaps the only thing that could make the insulin market worse: more government involvement.
And see the final agenda item, sending EMS bill to the committee on government operations?
Emergency Medical Services (EMS) were placed under MDHHS control by the Snyder administration. Not only does MMDHS control EMS licensing, testing, and education qualifications, but it also governs the regional EMS command and control power structure that sets practices (removing legal liability) and directs personnel in the field.
It's like a paramilitary organization, all under the label of health.
Wednesday, February 28, 2024
TIME: 12:15 PM or after committees are given leave by the House to meet, whichever time is later.AGENDA:
Presentation on Diabetes.
HB 4890 (Rep. VanderWall)
Health; pharmaceuticals; insulin production program; establish.HB 5519 (Rep. Conlin)
Economic development; Michigan strategic fund; insulin production program; include in report of activities.Refer to the House Committee on Government Operations:
SB 249 (Sen. Hertel)
Health occupations; emergency medical services personnel; examinations for certain emergency medical services personnel; modify, and require certain notices from education program sponsors.OR ANY BUSINESS PROPERLY BEFORE THIS COMMITTEE
California tried this back in 2020. Gov. Newsom announced a state insulin manufacturing project, and CA passed a law the same year. Insulin production was projected to begin as soon as early 2024, but despite frequent headlines in 2023 and a website ready to sell - nada.
For this and the following reasons, diabetics probably won't want to hold their breath for Michigan insulin.
Despite ongoing shortages, Crain's Detroit recently published, "Should Michigan get into the insulin business? Dropping market prices could thwart plan." The article is behind a paywall, but the title alone says a lot.
I'm still seeing $150-$300+ per vial on GoodRX, but they agree there's been a drop of approximately 10%.
Why is the price of insulin dropping?
President Biden and Congress would like to credit Medicare price caps and other federal policy changes.
BUT - and as a dairy farmer's daughter I absolutely love this - Science Alert has a far more entertaining explanation.
Good old competition from the world of agricultural research!
https://www.sciencealert.com/scientists-engineer-cow-that-makes-human-insulin-proteins-in-its-milk
Scientists Engineer Cow That Makes Human Insulin Proteins in Its Milk
18 March 2024 | ByJESS COCKERILLA genetically modified cow has produced proteins needed for human insulin in its milk, and the scientists behind the experiment have high hopes that a herd of these cattle could solve the world's insulin supply problems.
If such a herd were viable – and, based on this first case, that's still a long way off – the researchers think it could out-compete current insulin production methods, which rely on genetically modified yeast and bacteria.
http://www.gene.com/media/press-releases/4160/1978-09-06/first-successful-laboratory-production- o">Insulin – and its role in diabetes – was first discovered in 1921, and for many years diabetics were treated with insulin sourced from the pancreases of cattle and pigs.
But in 1978, the first 'human' insulin was produced using proteins from genetically engineered E. coli bacteria, which, along with similar processes that use yeast instead of bacteria, is the main source of medical insulin to this day.
While turning to cows for human insulin supply isn't new, the new study is the first time 'human' insulin production has been achieved in a genetically modified bovine.
The research team, led by animal scientist Matt Wheeler from the University of Illinois Urbana-Champaign, inserted a particular segment of human DNA that codes for proinsulin (a protein that's converted to insulin) into the cell nuclei of 10 cow embryos, which were then inserted into the wombs of normal cows.
Only one of these genetically modified embryos developed into a pregnancy, leading to the natural birth of a living, transgenic calf.
When it reached maturity, the team made a variety of attempts to get the genetically modified cow pregnant, by artificial insemination, in vitro fertilization, and even the old-fashioned way. None were successful, but the team notes this may be more to do with how the embryo was created than the fact it was genetically modified.
Eventually they were able to get the cow to lactate via hormonal induction, using an undisclosed method attributed to animal reproduction technologist Pietro Baruselli from the University of São Paulo.
The cow didn't lactate as much as it would during a pregnancy, but what little milk it did produce over a month was examined to look for specific proteins, using western blotting and mass spectrometry.
The blotting revealed two bands with similar molecular masses to human proinsulin and insulin, which were not present in the milk of non-transgenic cows. Mass spectrometry indicated the presence of the C-peptide that's removed from human proinsulin in the process of creating insulin, which suggests that enzymes in the cow's milk may have converted the 'human' proinsulin into insulin.
"Our goal was to make proinsulin, purify it out to insulin, and go from there. But the cow basically processed it herself. She makes about three to one biologically active insulin to proinsulin," Wheeler says.
In 2014, a similar kind of genetic modification was achieved in mice, whose milk contained up to 8.1 grams per liter of human proinsulin. Comparable concentrations were not reported in this new study, but that hasn't stopped Wheeler from thinking about scaling up.
A typical unit of insulin is 0.0347 milligrams, so if, as Wheeler proposes, each cow could make one gram of insulin per liter of milk, that's 28,818 units of insulin.
"You'd need specialized, high-health-status facilities for the cattle, but it's nothing too out of the ordinary for our well-established dairy industry," he says.
"I could see a future where a 100-head herd… could produce all the insulin needed for the country. And a larger herd? You could make the whole world's supply in a year."
This research was published in Biotechnology Journal.
Like most expensive products, high insulin prices will last only as long as Big Pharma can lobby to extend patent protection and otherwise block competition from generic knock-offs.
And it's not just insulin, but all biologic (cell-based) drugs. Some of them for cancer, rheumatoid arthritis, and other diseases cost thousands of dollars per dose.
It's pretty amazing how far manufacturers will go to keep your pharmacist from substituting biologic equivalents for originals like Lantus, Humalog, etc.
I testified against Big Pharma efforts to erect Michigan state legal barriers to "generic" biologics in 2018. The rest of that story is here.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.












